• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cardiometabolic profile of young women with hypoprolactinemia.年轻低泌乳素血症女性的心脏代谢特征。
Endocrine. 2022 Oct;78(1):135-141. doi: 10.1007/s12020-022-03145-1. Epub 2022 Jul 29.
2
Autoimmune Thyroiditis Attenuates Cardiometabolic Effects of Cabergoline in Young Women With Hyperprolactinemia.自身免疫性甲状腺炎可减轻催乳素血症年轻女性中卡麦角林的心脏代谢作用。
J Clin Pharmacol. 2023 Aug;63(8):886-894. doi: 10.1002/jcph.2245. Epub 2023 May 8.
3
Vitamin D Status Determines Cardiometabolic Effects of Cabergoline in Women with Elevated Prolactin Levels: A Pilot Study.维生素 D 状况决定了卡麦角林对高催乳素血症女性的心脏代谢影响:一项初步研究。
Nutrients. 2023 May 14;15(10):2303. doi: 10.3390/nu15102303.
4
Cabergoline-Induced Hypoprolactinemia May Attenuate Cardiometabolic Effects of Atorvastatin: A Pilot Study.卡麦角林引起的低催乳素血症可能会减弱阿托伐他汀的心脏代谢作用:一项初步研究。
Cardiology. 2022;147(5-6):497-506. doi: 10.1159/000527333. Epub 2022 Oct 4.
5
Impaired Cardiometabolic Effects of Bromocriptine in Men With Early-Onset Androgenic Alopecia.早期雄激素性脱发男性中溴隐亭对代谢心脏影响受损。
J Clin Pharmacol. 2023 Mar;63(3):345-351. doi: 10.1002/jcph.2163. Epub 2022 Nov 2.
6
Cardiometabolic Effects of Cabergoline and Combined Oral Contraceptive Pills in Young Women with Hyperprolactinemia: A Pilot Study.卡麦角林与复方口服避孕药对高泌乳素血症年轻女性的心脏代谢影响:一项初步研究
J Clin Med. 2023 Apr 29;12(9):3208. doi: 10.3390/jcm12093208.
7
Cardiometabolic Risk Factors in Men with Elevated Macroprolactin Content: A Pilot Study.大泌乳素含量升高男性的心脏代谢危险因素:一项初步研究。
Exp Clin Endocrinol Diabetes. 2021 Jan;129(1):7-13. doi: 10.1055/a-0902-4439. Epub 2019 Jun 11.
8
Cardiometabolic risk factors in young women with macroprolactinaemia.年轻女性肢端肥大症患者的心脏代谢危险因素。
Endokrynol Pol. 2019;70(4):336-341. doi: 10.5603/EP.a2019.0013. Epub 2019 Mar 7.
9
Different effects of cabergoline and bromocriptine on metabolic and cardiovascular risk factors in patients with elevated prolactin levels.卡麦角林和溴隐亭对催乳素水平升高患者代谢及心血管危险因素的不同影响。
Basic Clin Pharmacol Toxicol. 2015 Mar;116(3):251-6. doi: 10.1111/bcpt.12307. Epub 2014 Sep 11.
10
Different Effects of Atorvastatin on Cardiometabolic Risk Factors in Young Women With and Without Hyperprolactinemia.阿托伐他汀对伴有和不伴有高泌乳素血症的年轻女性心血管代谢危险因素的不同影响。
J Clin Pharmacol. 2019 Jan;59(1):83-89. doi: 10.1002/jcph.1301. Epub 2018 Aug 21.

引用本文的文献

1
The impact of hypoprolactinemia on cardiometabolic effects of metformin in young women: a pilot prospective cohort study.低催乳素血症对年轻女性二甲双胍心脏代谢效应的影响:一项前瞻性队列试点研究。
J Endocrinol Invest. 2025 Jul 25. doi: 10.1007/s40618-025-02645-x.
2
A Retrospective Study in Trans Individuals Undergoing Gender Affirming Testosterone Treatment: Can Changes in Prolactin Counteract the Negative Effects on the Lipid Profile?一项针对接受性别肯定睾酮治疗的跨性别者的回顾性研究:催乳素的变化能否抵消对血脂谱的负面影响?
Biomedicines. 2024 Dec 30;13(1):66. doi: 10.3390/biomedicines13010066.
3
Mildly elevated serum prolactin level may be a protective factor for preventing thickening of the carotid intima-media in patients with type 2 diabetes mellitus.轻度升高的血清催乳素水平可能是2型糖尿病患者预防颈动脉内膜中层增厚的一个保护因素。
Endocr Connect. 2024 Dec 19;14(1). doi: 10.1530/EC-24-0285. Print 2025 Jan 1.
4
Increased Cardiometabolic Risk in Men with Hypoprolactinemia: A Pilot Study.男性低催乳素血症与更高的心血管代谢风险相关:一项初步研究。
Biomolecules. 2024 Oct 20;14(10):1335. doi: 10.3390/biom14101335.
5
What do we know about abnormally low prolactin levels in polycystic ovary syndrome? A narrative review.关于多囊卵巢综合征中催乳素水平异常降低我们了解多少?一项叙述性综述。
Rev Endocr Metab Disord. 2024 Dec;25(6):1127-1138. doi: 10.1007/s11154-024-09912-x. Epub 2024 Oct 19.
6
The molecular basis of hypoprolactinaemia.低催乳素血症的分子基础。
Rev Endocr Metab Disord. 2024 Dec;25(6):967-983. doi: 10.1007/s11154-024-09906-9. Epub 2024 Oct 17.
7
Drug induced hypoprolactinemia.药物性低催乳素血症
Rev Endocr Metab Disord. 2024 Dec;25(6):1003-1011. doi: 10.1007/s11154-024-09909-6. Epub 2024 Sep 23.
8
Isolated hypoprolactinemia: The rarest of the rare?孤立性低催乳素血症:极其罕见中的罕见?
Rev Endocr Metab Disord. 2024 Dec;25(6):1047-1064. doi: 10.1007/s11154-024-09901-0. Epub 2024 Sep 13.
9
Autoimmune Thyroiditis Mitigates the Effect of Metformin on Plasma Prolactin Concentration in Men with Drug-Induced Hyperprolactinemia.自身免疫性甲状腺炎减轻二甲双胍对药物性高催乳素血症男性血浆催乳素浓度的影响。
Pharmaceuticals (Basel). 2024 Jul 23;17(8):976. doi: 10.3390/ph17080976.
10
Could low prolactin levels after radiotherapy predict the onset of hypopituitarism?放疗后低催乳素水平能否预测垂体功能减退的发生?
Rev Endocr Metab Disord. 2024 Dec;25(6):1013-1025. doi: 10.1007/s11154-024-09900-1. Epub 2024 Aug 22.

本文引用的文献

1
Sexual function and depressive symptoms in men with hypoprolactinaemia secondary to overtreatment of prolactin excess: A pilot study.男性高催乳素血症过度治疗继发低催乳素血症与性功能和抑郁症状的关系:一项初步研究。
Endocrinol Diabetes Nutr (Engl Ed). 2022 Apr;69(4):279-288. doi: 10.1016/j.endien.2021.03.004.
2
Impaired metabolic effects of metformin in men with early-onset androgenic alopecia.患有雄激素性脱发的早发性男性中二甲双胍代谢作用受损。
Pharmacol Rep. 2022 Feb;74(1):216-228. doi: 10.1007/s43440-021-00347-8. Epub 2021 Dec 12.
3
Sexual function and depressive symptoms in young women with hypoprolactinaemia.年轻低泌乳素血症女性的性功能与抑郁症状。
Clin Endocrinol (Oxf). 2020 Oct;93(4):482-488. doi: 10.1111/cen.14283. Epub 2020 Jul 26.
4
Prolactin - a pleiotropic factor in health and disease.催乳素 - 健康与疾病中的多效因子。
Nat Rev Endocrinol. 2019 Jun;15(6):356-365. doi: 10.1038/s41574-019-0194-6.
5
Different effects of fenofibrate on cardiometabolic risk factors in young women with and without hyperprolactinemia.非诺贝特对伴有和不伴有高泌乳素血症的年轻女性心血管代谢危险因素的不同影响。
Pharmacol Rep. 2019 Feb;71(1):61-66. doi: 10.1016/j.pharep.2018.09.004. Epub 2018 Sep 6.
6
Different Effects of Atorvastatin on Cardiometabolic Risk Factors in Young Women With and Without Hyperprolactinemia.阿托伐他汀对伴有和不伴有高泌乳素血症的年轻女性心血管代谢危险因素的不同影响。
J Clin Pharmacol. 2019 Jan;59(1):83-89. doi: 10.1002/jcph.1301. Epub 2018 Aug 21.
7
The effects of hyperprolactinemia and its control on metabolic diseases.高催乳素血症及其控制对代谢性疾病的影响。
Expert Rev Endocrinol Metab. 2018 Mar;13(2):99-106. doi: 10.1080/17446651.2018.1434412. Epub 2018 Feb 7.
8
Metabolic Syndrome in Hyperprolactinemia.高泌乳素血症中的代谢综合征。
Front Horm Res. 2018;49:29-47. doi: 10.1159/000486000. Epub 2018 Apr 5.
9
Carotid intima-media thickness and anti-hypertensive treatment: Focus on angiotensin II receptor blockers.颈动脉内膜中层厚度与降压治疗:关注血管紧张素Ⅱ受体阻滞剂。
Pharmacol Res. 2018 Mar;129:20-26. doi: 10.1016/j.phrs.2018.01.007. Epub 2018 Jan 31.
10
The prolactin receptor: Diverse and emerging roles in pathophysiology.催乳素受体:在病理生理学中的多样及新出现的作用
J Clin Transl Endocrinol. 2015 May 16;2(3):85-91. doi: 10.1016/j.jcte.2015.05.001. eCollection 2015 Sep.

年轻低泌乳素血症女性的心脏代谢特征。

Cardiometabolic profile of young women with hypoprolactinemia.

机构信息

Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Katowice, Poland.

Department of Pediatrics in Bytom, School of Health Sciences in Katowice, Medical University of Silesia, Katowice, Poland.

出版信息

Endocrine. 2022 Oct;78(1):135-141. doi: 10.1007/s12020-022-03145-1. Epub 2022 Jul 29.

DOI:10.1007/s12020-022-03145-1
PMID:35906342
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9474346/
Abstract

PURPOSE

Unlike hyperprolactinemia, clinical significance of prolactin deficiency remains poorly understood. The aim of this study was to assess the cardiometabolic profile of patients with low prolactin levels.

METHODS

The study population consisted of three groups of young women. Two groups were chronically treated with cabergoline but differed in prolactin levels, which were either abnormally low (group A; n = 16) or within the reference range (group B, n = 23). Group C, serving as a control group, included 28 drug-naïve women with normal prolactin levels. The dose of cabergoline in group A was then tapered down. Glucose homeostasis markers, plasma lipids and circulating levels of hormones, uric acid, high-sensitivity C-reactive protein (hsCRP), fibrinogen and homocysteine, as well as the carotid intima-media thickness were assessed at baseline and 6 months later.

RESULTS

Compared with subjects with normal prolactin levels, women with hypoprolactinemia had higher levels of 2-h postchallenge glucose, glycated hemoglobin, triglycerides, uric acid, hsCRP and fibrinogen, lower values of HDL-cholesterol, total testosterone and free androgen index, as well as reduced insulin sensitivity. No differences in these variables were observed between groups B and C. Apart from prolactin normalization, cabergoline dose reduction reversed all laboratory disturbances reported in group A.

CONCLUSION

The obtained results suggest that hypoprolactinemia in women of reproductive age may increase cardiometabolic risk.

摘要

目的

与高催乳素血症不同,催乳素缺乏的临床意义仍知之甚少。本研究旨在评估低催乳素水平患者的心脏代谢特征。

方法

研究人群包括三组年轻女性。两组患者长期接受卡麦角林治疗,但催乳素水平不同,一组催乳素水平异常低(A 组,n=16),另一组催乳素水平在参考范围内(B 组,n=23)。C 组为对照组,包括 28 名未服用药物且催乳素水平正常的女性。然后逐渐减少 A 组的卡麦角林剂量。在基线和 6 个月后评估葡萄糖稳态标志物、血浆脂质和循环激素、尿酸、高敏 C 反应蛋白(hsCRP)、纤维蛋白原和同型半胱氨酸水平以及颈动脉内膜中层厚度。

结果

与催乳素水平正常的受试者相比,催乳素缺乏的女性 2 小时餐后血糖、糖化血红蛋白、甘油三酯、尿酸、hsCRP 和纤维蛋白原水平更高,高密度脂蛋白胆固醇、总睾酮和游离雄激素指数水平更低,胰岛素敏感性降低。B 组和 C 组之间这些变量没有差异。除了催乳素正常化外,卡麦角林剂量减少还逆转了 A 组报告的所有实验室异常。

结论

研究结果表明,生育年龄妇女的低催乳素血症可能会增加心脏代谢风险。